Projects per year
Personal profile
Research interests
1. Economic and behavioural evidence of precision medicine, applying cost-effectiveness analysis and stated preference methods. 2. Establishing gene-based precision public health in Australia. 3. Methodologies for the economic evaluation of healthcare technologies.
Fingerprint
Dive into the research topics where Shan Jiang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
MUAPS Top-Up Scholarship
Cutler, H. (Primary Chief Investigator), Parkinson, B. (Chief Investigator) & Jiang, S. (PhD Student)
14/12/23 → 13/12/26
Project: Research
-
Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation
Jiang, S., Li, B., Parkinson, B., Li, S. & Gu, Y., 16 Apr 2025, In: Global Health Research and Policy. 10, 1, p. 1-5 5 p., 17.Research output: Contribution to journal › Comment/opinion › peer-review
Open AccessFile1 Citation (Scopus)6 Downloads (Pure) -
Cost-effectiveness of toripalimab plus chemotherapy versus chemotherapy as first-line treatment for advanced non-small cell lung cancer in China: a societal perspective
Lian, D., Gan, Y., Yang, Y., Xiao, D., Xiang, Y., Jiang, S., Gu, Y. & Chen, Y., 2025, In: Expert Review of Pharmacoeconomics and Outcomes Research. 25, 4, p. 587-596 10 p.Research output: Contribution to journal › Article › peer-review
-
Genomic sequencing technologies for rare disease in mainstream healthcare: the current state of implementation
Mackley, M. P., Agrawal, P. B., Ali, S. S., Archibald, A. D., Dawson-McClaren, B., Ellard, H., Freeman, L., Gu, Y., Jayasinghe, K., Jiang, S., Kirk, E. P., Lewis, C., McEwen, A., Nisselle, A., Quinlan, C., Terrill, B., Tutty, E. & McNeill, A., Nov 2025, In: European Journal of Human Genetics. 33, 11, p. 1402-1413 12 p.Research output: Contribution to journal › Review article › peer-review
-
How policymakers value end-of-life treatments for rare and common diseases in China: evidence from a contingent valuation study
Cheng, H., Jiang, S., Liu, T., Li, B., Chen, S., Li, A., Chen, H., Wang, H. & Gu, Y., Dec 2025, In: Global Health Research and Policy. 10, 1, p. 1-10 10 p., 38.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Downloads (Pure) -
Physicians’ risk and time preferences and their willingness to detect and disclose genomic secondary findings: A multiple price list experiment
Jiang, S., Wang, H., Chen, Z., Zang, X., Jiang, Y., Zhou, Z. & Gu, Y., Mar 2025, In: Pharmacoeconomics and Policy. 1, 1, p. 25-32 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile18 Downloads (Pure)
-
Eliciting Health Inequality Aversion Among the Chinese Population: A Parameter for Distributional Cost-Effectiveness Analysis in China
Jiang, S. (Speaker)
29 Apr 2024Activity: Talk or presentation › Invited talk
-
Evaluating cost-effectiveness and distributional impact of Breast Cancer Screening: A distributional cost-effectiveness analysis incorporating patient preferences
Jiang, S. (Speaker)
20 Sept 2024Activity: Talk or presentation › Presentation
-
Evaluating Cost-Effectiveness and Distributional Impact of Population-wide HBOC Screening: A DCEA incorporating patient preferences
Jiang, S. (Speaker)
2 Dec 2024Activity: Talk or presentation › Invited talk
-
The Lancet Regional Health - Western Pacific (Journal)
Jiang, S. (Reviewer)
2024 → …Activity: Peer-review and editorial of research outputs › Publication Peer-review
-
Discrete Choice Experiment: Introduction, Design, and Application
Jiang, S. (Speaker)
15 Mar 2024Activity: Talk or presentation › Invited talk